Neurochemical and behavioral profiles of 1-(1-naphthyl) piperazine in rats

Journal of the College of Physicians and Surgeons Pakistan

Volumn 11, Issue 1, 2001, Pages 50-56

  Batool, F ^a   Siddiqui, S ^a   Haleem, D J ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Behavioral medicine; Maze learning; Narepinephrine; Piperazines; Serotinin agonists

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (1 NAPHTHYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 3 HYDROXYBENZYLHYDRAZINE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; 6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CATECHOL; CORTICOSTERONE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MUSCLE RELAXANT AGENT; NEUROTRANSMITTER; NORADRENALIN; PIPERAZINE DERIVATIVE; QUIPAZINE; SEDATIVE AGENT; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SODIUM CHLORIDE; TRYPTOPHAN; UNINDEXED DRUG;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; METABOLITE; MOBILIZATION; NEUROCHEMISTRY; NONHUMAN; NORADRENALIN BRAIN LEVEL; RAT; RAT STRAIN; SEROTONIN BRAIN LEVEL; TRYPTOPHAN BRAIN LEVEL;

EID: 0035099718     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Specificity of serotonergic involvement in the decrease of food intake induced by quipazine in the rat
2. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67
3. The future of 5-HT-1A receptor agonists. (Arylpiperazine derivatives)
4. Serotonin and anxiety: A review of current research and clinical implications
5. Serotonin-anatgonist effects of 1-(1-naphthyl) piperazine on operant on operant behavior of squirrel monkeys
6. In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guina pig brain
7. Anorexigenic and ancillary actions of MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine; CPP)
8. Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents
9. Differential actions of serotonin antagonists in two behavioral models of serotonin receptor activation in the rat
10. Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N, N-dimethyltryptamine in the rat
11. Distinct functions for dopamine and serotonin in locomotor behavior: Evidence using the 5-HT-1 agonist RU-24969 in globus pallidus-lesioned rats
12. The effects of quipazine on serotonin metabolism in rat brain
13. Attempts to measure endogenous levels of dopa and 5-HT in rat brain
14. Substituted piperazines as central serotonin agonists: Comprative specificity of the post-synaptic actions of quipazine and TFMPP
15. Effects of restraint on rat brain region 5-HT synthesis rate following behavioral adaptation to repeat restraint
16. Enhancement of brain regional tryptophan concentration following administration of diazepam: A dose related study
17. Role of hippocampal 5-HT-1A receptors on elevated plus maze exploration after a single restraint experience
18. Adaptation of female rats to stress: Shift to male pattern by inhibition of corticosterone synthesis
19. Regionally specific effects of diazepam on brain serotonin metabolism in rats: Sustained effect following repeated administration
20. The 5-HT syndrome and the drug discrimination paradigm in rats: Application in behavioral studies on the central 5-HT system
21. 5-HT-1 and 5-HT-2 binding characteristics of some quipazine analogues
22. Effect of 8-OH-DPAT on motor activity in the rat
23. Single administration of 5-HT-1A agonists decreases 5-HT-1A presynaptic, but not postsynaptic receptor-mediated response: Relationship to antidepressant-like action
24. Effect of m-CPP and TFMPP on locomotor activity
25. Pharmacological differentiation and characterization of 5-HT-1A, 5-HT-1B and 5-HT-1C binding sites in the rat frontal cortex
26. The behavioral effects of RU-24969, a suggested 5-HT-1 receptor agonist in rodents and the effect on the behavior of treatment with antidepressants
27. 1-Naphthylpiperazine derivatives as potential atypical anti-psychotic agents
28. Animal models of anxiety: The effect of compounds that modify 5-HT neurotransmission
29. Effects of 5-HT-4 receptor antagonists on rat behavior in the elevated plus-maze test
30. 5-HT drugs in animal models of anxiety
31. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
32. 5-HT drugs in animal models of anxiety
33. Substituted phenylpiperazines as serotonin agonists: Structural determinants of potency and interaction with receptor subtypes
34. Evidence that m-CPP may have behavioral effects mediated by central 5-HT-1C receptors
35. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and mtrifluoromethylpiperazine
36. Anxiogenic-like effects of m-CPP and TFMPP in animal models are opposed by 5-HT-1C receptor antagonists
37. 1-(1-Naphthyl) piperazine, a central serotonin agonist
38. The effect of selective 5-HT-1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-HT in different regions of rat brain
39. Effect of 1-(m-trifluoromethylphenyl) piperazine on 3H-serotonin binding to membranes from rat brain in vitro
40. Effects of a selective 5-HT uptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain
41. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-HT-1A agonists with potential anxiolytic properties
42. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis
43. Differential effects of 5-HT-1A-selective drugs on the 5-HT behavioral syndrome
44. 5-HT-1D Serotonin receptors: Results of a structure-affinity investigation
45. Neurochemistry and neurophysiology of buspirone and gepirone interactions at presynaptic and postsynaptic 5-HT-1A receptors
46. The 5-HT-1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in the rat brain in vivo
47. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug
48. Region-selective effects by 8-OH-DPAT on brain dopamine synthesis in vivo
49. Effects of buspirone and its metabolite 1-(2-pyrimidinyl) piperazine, on brain monoamines and their metabolites in rats
50. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-HT-1A receptor activation
51. Effect of a 5-HT-1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats
52. Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2-adrenoceptors but not by adenosine receptors
53. Effect of 5-HT-1A receptor agonist on pattern of rat motor activity in relation to effect on forebrain monoamine synthesis
54. Sustained-5-HT-release-inhibitory and anxiolytic-like action of the partial 5-HT-1A receptor agonist, buspirone, after prolonged chronic administration
55. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze
56. Behavioral studies with anxiolytic drugs VI: Effects on punished responding of drugs interacting with serotonin receptor subtypes